Announced
Synopsis
Cinven, a private investment firm, agreed to acquire a majority stake in BioAgilytix, a provider of molecular bioanalysis and bioanalytical test services, from Caledonia Investments, a London-based investment trust. Cobepa, a private investment firm, and GHO Capital will remain a significant minority investor in the company. Financial terms were not disclosed. "As we move into our next chapter of our evolution, Cinven will provide the additional resources that will empower us to expand not only our geographical reach but will also enable us to invest further in our talent and facilities around the globe to meet the ever-growing needs of our customers," Jim Datin, BioAgilytix President and CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.